Results 171 to 180 of about 45,417 (262)

Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems.

, 1986
Joyce Rauch, Marion Tannenbaum, H Tannenbaum, H Ramelson, P.R. Cullis, Colin Tilcock, Michael J. Hope, A S Janoff   +7 more
openalex   +1 more source

Lymphotoxin and an associated 33-kDa glycoprotein are expressed on the surface of an activated human T cell hybridoma [PDF]

, 1991
Jeffrey L. Browning, Matthew J. Androlewicz, Carl F. Ware   +2 more
openalex   +1 more source

Morphological differences in myofibre size and shape: A comparative study of the soleus, gastrocnemius, triceps brachii and vastus lateralis in humans and mice

Journal of Anatomy, Volume 248, Issue 1, Page 126-139, January 2026.
Myofibre size and shape were investigated in functionally distinct muscles of humans and mice using ATPase histochemistry and immunofluorescence. In both species, soleus myofibres were found to be larger, more irregularly shaped, and more heterogeneous compared to other muscles. These findings may have implications for biomedical research and potential
Casper Soendenbroe, Rene B. Svensson, Bettina Mittendorfer, S. Peter Magnusson, Abigail L. Mackey, Jesper L. Andersen   +5 more
wiley   +1 more source

A microenvironment-driven HLA-II-associated insulin neoantigen elicits persistent memory T cell activation in diabetes. [PDF]

Nat Immunol
Srivastava N, Vomund AN, Yu R, Peterson OJ, Yang Y, Turicek DP, Abousaway O, Li T, Kain L, Stone P, Ansar A, Clement CC, Sharma S, Melhem R, Zhang B, Liu C, Joglekar AV, Hu H, Hsieh CS, Campisi L, Santambrogio L, Teyton L, Unanue ER, Arbelaez AM, Lichti CF, Wan X.   +25 more
europepmc   +1 more source

Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas.

Proceedings of the National Academy of Sciences of the United States of America, 1982
J. Kappler, J. White, D. Wegmann, E. Mustain, P. Marrack   +4 more
semanticscholar   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source

Integrative and Emerging Models in Antibody Research: A Comprehensive Review. [PDF]

Antib Ther
Devasani JR, Guntuku G, Sarabu P, Muthyala MKK, Palla MS, Subrahmanyam Volety M.   +5 more
europepmc   +1 more source

Flanking Residues Are Central to DO11.10 T Cell Hybridoma Stimulation by Ovalbumin 323–339

, 2012
Benjamin M. Roy, Dmitriy V. Zhukov, Jennifer A. Maynard   +2 more
openalex   +2 more sources

Mouse spleen dendritic cells present soluble antigens to antigen-specific T cell hybridomas. [PDF]

, 1983
Geoffrey H. Sunshine, Daniel P. Gold, Henry H. Wortis, Philippa Marrack, John W. Kappler   +4 more
openalex   +1 more source

Rabbit monoclonal antibodies: generating a fusion partner to produce rabbit-rabbit hybridomas.

Proceedings of the National Academy of Sciences of the United States of America, 1995
H. Spieker-Polet, P. Sethupathi, P. Yam, K. Knight   +3 more
semanticscholar   +1 more source